Too true Poyndexter...quite a bit of money to be made by a smart player willing to refinance the debt whilst accumulating some stock. Clever play if you have ~$50 million to play with.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
